LIU Xiangke, GUO Xiaopei. Comparison of two endoscopic surgeries in the treatment of colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 22-25. DOI: 10.7619/jcmp.202016006
Citation: LIU Xiangke, GUO Xiaopei. Comparison of two endoscopic surgeries in the treatment of colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 22-25. DOI: 10.7619/jcmp.202016006

Comparison of two endoscopic surgeries in the treatment of colorectal cancer

More Information
  • Received Date: May 26, 2020
  • Available Online: September 14, 2020
  • Objective To investigate the effect of endoscopic endoscopic submucosal dissection(EMR)and endoscopic submucosal dissection(ESD)in the treatment of colorectal cancer. Methods A total of 164 patients with colorectal cancer were selected and divided into control group and research group according to the random number table method. The control group received EMR, while the research group received ESD. The operation time, intraoperative blood loss and excision of lesions with different diameters of the two groups were compared. The levels of tumor markers such as cancer antigen 125(CA125), CA199 and carcinoembryonic antigen(CEA)in the two groups before and after treatment were detected and analyzed, and the incidence of postoperative complications was compared. Results The operative time of the study group was longer, and the intraoperative blood loss was more than that of the control group(P<0.05). The rates of complete resection of lesions with diameter< 2 cm in the control group and the research group were 80.00% and 86.11%, respectively, but there were no significant differences(P>0.05). The rate of complete resection of lesions with diameter ≥2 cm in the research group was 91.30%, which was significantly higher than 61.70% of the control group(P<0.05). There were no significant differences in the levels of CA125, CA199 and CEA between the two groups before treatment(P>0.05). After treatment, the levels of CA125, CA199 and CEA in the research group were lower than those in the control group(P<0.05). The incidence of complications in the study group was 18.29%, which was significantly higher than 7.32% in the control group(P<0.05). Conclusion EMR and ESD both have advantages in the treatment of colorectal cancer, and the corresponding surgical methods can be selected reasonably - according to the actual situations of patients.
  • 伦伟健, 黄鹤, 梁晓燕. 内镜下黏膜切除术与黏膜剥离术治疗早期结直肠癌的疗效及安全性比较分析[J]. 广西医学, 2017, 39(8): 1168-1170

    , 1174.
    冯金龙. 结直肠内镜剥离术对老年结直肠癌患者应激反应的影响[J]. 中国肛肠病杂志, 2019, 39(10): 14-16.
    牛巍巍, 贾文秀, 张晓岚. 内镜在炎症相关结直肠癌监测和治疗中的应用[J]. 河北医科大学学报, 2019, 40(9): 1095-1099.
    赵玉兰, 章璧莹, 毛建山. 内镜黏膜下剥离术与外科手术治疗早期结直肠癌的Meta分析[J]. 湖州师范学院学报, 2019, 41(8): 67-73.
    刘鹏, 花亚伟, 张占东, 等. 内镜黏膜下剥离术治疗早期结直肠癌及其癌前病变的临床效果观察[J]. 河南医学研究, 2017, 26(5): 801-802.
    张亮, 柳舟, 陈军, 等. 内镜下黏膜切除术与内镜黏膜下剥离术治疗结直肠癌临床疗效的Meta分析[J]. 中国内镜杂志, 2019, 25(11): 9-18.
    蒋静, 刘美宏, 李丹, 等. 内镜下黏膜剥离及切除术治疗早期直肠癌的预后比较[J]. 现代消化及介入诊疗, 2019, 24(3): 236-240.
    刘晓凌. 内镜黏膜下剥离术治疗早期结直肠癌的效果[J]. 深圳中西医结合杂志, 2019, 29(4): 103-105.
    常树勋, 申辰, 位乐乐. 内镜黏膜下剥离术治疗早期结直肠癌的安全性及可行性分析[J]. 中国肛肠病杂志, 2019, 39(2): 1-3.
    吴成甫. 内镜黏膜下剥离术治疗早期结直肠癌及癌前病变术后延迟性出血的危险因素分析[J]. 中国肛肠病杂志, 2018, 38(11): 14-16.
    中华人民共和国国家卫生和计划生育委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J]. 中国实用外科杂志, 2018, 38(10): 1089-1103.
    许愈强, 李红灵. 注水法内镜下黏膜切除术治疗大肠息肉的应用[J]. 医学理论与实践, 2018, 31(18): 2695-2697

    , 2719.
    徐康, 金海林, 丁玺, 等. 内镜黏膜下剥离术治疗早期结直肠癌的应用价值与安全性评估[J]. 中国内镜杂志, 2018, 24(5): 17-22.
    徐子忠. 早期结直肠癌患者行内镜黏膜下剥离术的手术难度影响因素分析[J]. 结直肠肛门外科, 2017, 23(6): 731-734.
    王明贵, 高金海. 内镜下黏膜切除、剥离术治疗直肠早期癌的疗效及并发症影响因素研究[J]. 结直肠肛门外科, 2017, 23(5): 584-587.
    庄丛, 林白浪, 安学芳, 等. 奥马哈系统在内镜下黏膜剥离术治疗结直肠癌前病变出院后延续护理中的应用[J]. 广东医学, 2017, 38(18): 2889-2892.
    马丽, 李建军, 周跃进, 等. 炎症性肠病与直肠癌患者血清中CA199、CA125、CEA水平表达差异及临床意义[J]. 川北医学院学报, 2019, 34(6): 697-701.
    雷浩强, 阎向民, 韩延风, 等. 内镜下黏膜剥离术治疗早期直肠癌及癌前病变疗效观察[J]. 中国肿瘤临床与康复, 2017, 24(6): 715-717.

Catalog

    Article views (581) PDF downloads (15) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return